NCT00399269View on ClinicalTrials.gov

Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

June 30, 2007

Conditions
Anemia
Interventions
DRUG

Recombinant Human Erythropoietin alpha

Trial Locations (1)

Unknown

Dr. Shishir Gang, Nadiād

Sponsors
All Listed Sponsors
lead

Cadila Pharnmaceuticals

INDUSTRY

NCT00399269 - Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure | Biotech Hunter | Biotech Hunter